NO20030021L - Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV - Google Patents
Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IVInfo
- Publication number
- NO20030021L NO20030021L NO20030021A NO20030021A NO20030021L NO 20030021 L NO20030021 L NO 20030021L NO 20030021 A NO20030021 A NO 20030021A NO 20030021 A NO20030021 A NO 20030021A NO 20030021 L NO20030021 L NO 20030021L
- Authority
- NO
- Norway
- Prior art keywords
- dpp
- inhibitors
- heterocyclic compounds
- enzyme dpp
- compounds
- Prior art date
Links
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 title abstract 4
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002779 inactivation Effects 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200001040 | 2000-07-04 | ||
| PCT/DK2001/000467 WO2002002560A2 (en) | 2000-07-04 | 2001-07-04 | Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030021D0 NO20030021D0 (no) | 2003-01-03 |
| NO20030021L true NO20030021L (no) | 2003-03-03 |
Family
ID=8159598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030021A NO20030021L (no) | 2000-07-04 | 2003-01-03 | Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1561752A1 (cs) |
| KR (1) | KR20030014394A (cs) |
| CN (1) | CN1440288A (cs) |
| AT (1) | ATE299024T1 (cs) |
| BR (1) | BR0112123A (cs) |
| CA (1) | CA2411864A1 (cs) |
| CZ (1) | CZ200319A3 (cs) |
| DE (1) | DE60111849T2 (cs) |
| ES (1) | ES2244634T3 (cs) |
| IL (1) | IL153182A0 (cs) |
| NO (1) | NO20030021L (cs) |
| RU (1) | RU2003103103A (cs) |
| ZA (1) | ZA200209714B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06010571A (es) * | 2004-03-15 | 2007-02-16 | Takeda Pharmaceutical | Inhibidores de dipeptidil peptidasa. |
| AU2005267093B2 (en) * | 2004-07-23 | 2009-10-01 | Nuada Llc | Peptidase inhibitors |
| CN102276627B (zh) * | 2010-04-29 | 2013-07-31 | 山东轩竹医药科技有限公司 | 吡啶并杂环衍生物 |
| WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| CN103509023B (zh) * | 2012-06-20 | 2014-08-27 | 成都苑东药业有限公司 | 黄嘌呤衍生物 |
| CN105143229B (zh) | 2013-03-15 | 2017-06-30 | 海德拉生物科学有限公司 | 取代的黄嘌呤及其使用方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2205815A1 (de) * | 1972-02-08 | 1973-08-16 | Hoechst Ag | Piperazinderivate und verfahren zu ihrer herstellung |
| GB9020959D0 (en) * | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
-
2001
- 2001-07-04 CZ CZ200319A patent/CZ200319A3/cs unknown
- 2001-07-04 CN CN01812097A patent/CN1440288A/zh active Pending
- 2001-07-04 IL IL15318201A patent/IL153182A0/xx unknown
- 2001-07-04 BR BR0112123-5A patent/BR0112123A/pt not_active IP Right Cessation
- 2001-07-04 AT AT01947211T patent/ATE299024T1/de not_active IP Right Cessation
- 2001-07-04 RU RU2003103103/04A patent/RU2003103103A/ru not_active Application Discontinuation
- 2001-07-04 EP EP05008243A patent/EP1561752A1/en not_active Withdrawn
- 2001-07-04 ES ES01947211T patent/ES2244634T3/es not_active Expired - Lifetime
- 2001-07-04 CA CA002411864A patent/CA2411864A1/en not_active Abandoned
- 2001-07-04 KR KR1020027017726A patent/KR20030014394A/ko not_active Withdrawn
- 2001-07-04 DE DE60111849T patent/DE60111849T2/de not_active Expired - Fee Related
-
2002
- 2002-11-29 ZA ZA200209714A patent/ZA200209714B/xx unknown
-
2003
- 2003-01-03 NO NO20030021A patent/NO20030021L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2411864A1 (en) | 2002-01-10 |
| DE60111849T2 (de) | 2006-06-08 |
| ATE299024T1 (de) | 2005-07-15 |
| IL153182A0 (en) | 2003-06-24 |
| ES2244634T3 (es) | 2005-12-16 |
| EP1561752A1 (en) | 2005-08-10 |
| DE60111849D1 (de) | 2005-08-11 |
| CN1440288A (zh) | 2003-09-03 |
| CZ200319A3 (cs) | 2003-05-14 |
| NO20030021D0 (no) | 2003-01-03 |
| KR20030014394A (ko) | 2003-02-17 |
| ZA200209714B (en) | 2003-08-19 |
| RU2003103103A (ru) | 2004-08-20 |
| BR0112123A (pt) | 2003-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012272A (es) | Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv. | |
| WO2004033455A3 (en) | Hemisuccinate salts of heterocyclic dpp-iv inhibitors | |
| DE60225556D1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| WO2003024965A3 (en) | Heterocyclic compounds that are inhibitors of the enzyme dpp-iv | |
| ECSP055783A (es) | Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevención de diabetes | |
| BR0009167A (pt) | Inibidores de enzima impdh | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| ECSP055732A (es) | Inhibidores de la beta-amino heterocíclico dipeptidil peptidasa para el tratamiento o prevención de diabetes | |
| NO2007010I1 (no) | Sitagliptin, eventuelt i form av et farmasoytisk akseptabelt salt | |
| DE60330485D1 (de) | Zur behandlung von diabetes | |
| NO20070049L (no) | Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese | |
| MY138708A (en) | Biaryloxymethylarenecarboxylic acids | |
| GB0222495D0 (en) | Compounds | |
| MY142589A (en) | Benzimidazole derivatives : preparation and pharmaceutical applications | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| GB0222514D0 (en) | Organic compounds | |
| EA200401471A1 (ru) | Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов | |
| ATE384058T1 (de) | Thiazolderivate | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| AU2003260436A1 (en) | Pyrimidine compounds | |
| NO20030021L (no) | Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV | |
| WO2004056306A3 (de) | Verwendung von l-dopa, seiner derivate und diese verbindungen enthaltender arzneimittel zur prophylaxe psychotischer erkrankungen | |
| WO2002023784A3 (en) | Cysteine protease inhibitors |